Novo Nordisk India sales jump 40% after semaglutide price cuts
NewsBytes | May 8, 2026 6:40 PM CST
Branded drugs keep selling despite generics
Even with new GLP-1 generics selling for as low as $14 a month and market volume up 56%, branded drugs like Ozempic and Wegovy are still holding strong with 32,000 units sold in April.
According to Pharmarack's Sheetal Sapale, generics have mostly helped more people access treatment but haven't really cut into the popularity of big-name brands, especially since many doctors and patients still prefer them.
READ NEXT
-
Best Tax Saving Options in 2026: These 4 Investments Can Help You Save Lakhs Under Section 80C
-
8th Pay Commission: Salaries May Surge From Peons to IAS Officers if 3.83 Fitment Factor Is Approved
-
Petrol and Diesel Prices May Rise Before May 15 as Crude Oil Crosses $100 Per Barrel
-
PAN Card Fraud Alert: Your PAN Leak Could Turn You Into a Loan Defaulter Without Borrowing Money
-
ITR Filing 2026: Choosing the Wrong ITR Form Could Trigger a Tax Notice — Here’s the Right Option for Salaried Employees and Freelancers
